You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 101 No. 3, March 1970 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Syphilis and Biologic False Positive Reactors Among Leprosy Patients

Angelo T. Scotti, MD; Dan M. Mackey, MD; John R. Trautman, MD

Arch Dermatol. 1970;101(3):328-330.


Abstract

Of 206 leprosy patients, 40% (82) were found to have reactive nontreponemal tests for syphilis. Forty percent of these patients (33 of 82) were found to have reactive treponemal tests, either fluorescent treponemal antibody absorption test (FTA-ABS), Treponema pallidum immobilization test (TPI), or both. It was concluded that at least 16% of the leprosy patients studied had some serologic evidence suggestive of a treponemal infection either in the past or at present. Treponemal diseases may be common among leprosy patients, and may account for some of the reactive serologic tests usually called biologic false positive BFP. The FTA-ABS test was found to be more frequently reactive than the TPI among those leprosy patients studied. The rapid plasma reagin (RPR) card test was rather insensitive but seemed more specific than the venereal disease research laboratory test for syphilis (VDRL). Question of false-positive FTA-ABS tests in some of these patients could be neither established nor disproved.



Author Affiliations

Rochester, Minn; Atlanta; New Orleans

From the Venereal Disease Program (Drs. Scotti and Mackey), National Communicable Disease Center, Public Health Service, Atlanta; and the US Public Health Service Hospital, Carville, La (Dr. Trautman). Dr. Scotti is now a fellow in internal medicine at the Mayo Clinic, Rochester, Minn. Dr. Mackey is in private practice in Atlanta. Dr. Trautman is with the Venereal Disease Control Section, State Board of Health, New Orleans.


Footnotes

Accepted for publication Sept 24, 1969.

Reprint requests to Venereal Disease Program, National Communicable Disease Center, Atlanta 30333 (Dr. Scotti).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Syphilis and Leprosy
Murray
JAMA 1982;247:2097-2097.
ABSTRACT  

Epidemiology of Infectious Syphilis at a Tertiary Hospital
Drusin et al.
Arch Intern Med 1979;139:901-904.
ABSTRACT  

The Laboratory Diagnosis of Syphilis: New Concepts
JAFFE
ANN INTERN MED 1975;83:846-850.
ABSTRACT  

Society Transactions
Arch Dermatol 1971;103:540-559.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.